Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double Blind Trial to Evaluate the Efficacy and Safety of Dronedarone (400mg BID) Versus Amiodarone (600mg Daily for 28 Days, Then 200mg Daily Thereafter) for at Least 6 Months for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation (AF)

NCT00489736 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00489736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00489736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double Blind Trial to Evaluate the Efficacy and Safety of Dronedarone (400mg BID) Versus Amiodarone (600mg Daily for 28 Days, Then 200mg Daily Thereafter) for at Least 6 Months for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation (AF)
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2007
Completion date
October 31, 2008
Enrollment
504 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation